Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
dimanche, octobre 04
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Adicet Bio Inc
ACET
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$6.50
-0.14
-2.11%
Dern. MÀJ: Oct 2, 6:53 PM
$6.51
-0.13
-1.96%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Adicet Bio Analyst Price Targets - Benzinga
Adicet Bio Analyst Price Targets
Wall Street analyst price targets and consensus rating for Adicet Bio (ACET).
Analyst Ratings News
PRO
Wedbush Maintains Outperform on Adicet Bio, Raises Price Target to $28
Wedbush analyst Robert Driscoll maintains Adicet Bio (NASDAQ:ACET) with a Outperform and raises the price target from $25 to $28.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $34
HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $27 to $34.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $27 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $27 price target.
Benzinga Newsdesk
PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $90
Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $100 to $90.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27
HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $50 to $27.
Benzinga Newsdesk
PRO
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $100
Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $128 to $100.
Benzinga Newsdesk
Créez votre liste de surveillance
GRATUIT : Suivez les actions et les crypto-monnaies avec les meilleures notifications sur Internet
Cliquez ici pour commencer
People Also Watch
AbbVie Inc
NYSE:ABBV
$263.04
0.08%
Amgen Inc
NASDAQ:AMGN
$404
0.24%
Gilead Sciences Inc
NASDAQ:GILD
$144.91
0.12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
$504.73
-%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
$736.5
0.18%
Moderna Inc
NASDAQ:MRNA
$189.64
-0.19%
Natera Inc
NASDAQ:NTRA
$410.35
-%
argenx SE
NASDAQ:ARGX
$919.21
-%
Revolution Medicines Inc
NASDAQ:RVMD
$206.25
-0.19%
BeOne Medicines Ltd
NASDAQ:ONC
$351.99
-1.7%
Afficher toutes les 10 entreprises associées
